Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.71 -0.04 (-5.72%)
As of: Oct 20, 2026 · 9:41 AM EDT

Scinai Immunotherapeutics (SCNI) Accumulated Expenses (2021 - 2025)

Updated

Scinai Immunotherapeutics (SCNI) posted Accumulated Expenses of $441,000 for Q4 2025, down 16.3% from $527,000 a year earlier.

Analysis

Scinai Immunotherapeutics (SCNI) Accumulated Expenses (2021 - 2025) Analysis & Trends

Since Q4 2021, Scinai Immunotherapeutics has reported Accumulated Expenses for 5 quarters.

  • Annual Accumulated Expenses shows a four-year compound annual growth rate of 5.1% (FY2021 to FY2025).
  • In prior years, Scinai Immunotherapeutics' Accumulated Expenses was $527,000 in FY2024 (+14.3%), $461,000 in FY2023 (-39.0%), $756,000 in FY2022 (+109.4%) and $361,000 in FY2021.
  • The Q4 2025 figure stands as the lowest quarterly Accumulated Expenses since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,141.50 Bn 1,110.09 Bn 19.71 Bn
2 Johnson & Johnson 622.67 Bn 541.20 Bn 17.26 Bn
3 AbbVie 506.31 Bn 479.43 Bn 12.70 Bn
4 Merck 365.39 Bn 319.77 Bn 12.21 Bn
5 Novartis Ag 295.52 Bn 259.51 Bn 11.24 Bn
6 Astrazeneca 259.13 Bn 232.82 Bn 12.86 Bn
7 Amgen 231.97 Bn 187.36 Bn 7.24 Bn
8 Gilead Sciences 193.85 Bn 168.05 Bn 6.22 Bn
9 Pfizer 170.71 Bn 117.36 Bn 10.94 Bn
10 Scinai Immunotherapeutics 166,172.36 -8.10 Mn -1.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 441,000.00
Dec 31, 2024 527,000.00
Dec 31, 2023 461,000.00
Dec 31, 2022 756,000.00
Dec 31, 2021 361,000.00
API Access

Scinai Immunotherapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SCNI&period=max&api_key=YOUR_API_KEY